Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Polynoma Presenting Interim Phase III Data for Its Investigational Melanoma Vaccine, Seviprotimut-L, at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting 2019-11-06 20:00
Samsung Biologics and Ichnos Sciences Announce Agreement for Manufacture of ISB 830 2019-11-05 08:22
Luye Pharma's LY03004 Manufacturing Facility Successfully Passes U.S. FDA Pre-approval Inspection with Zero Observation 2019-11-05 00:39
China Biologic Products to Report Third Quarter 2019 Financial Results 2019-11-04 21:30
Mallinckrodt and Terumo BCT Announce UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for the Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults 2019-11-01 04:35
GC Pharma Reports Q3 2019 Results 2019-10-30 21:00
Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis 2019-10-28 20:30
HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH) 2019-10-26 19:00
Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences 2019-10-26 18:01
World first clinical trial commenced in alcohol use disorder 2019-10-24 12:01
GN Corporation and Edogawa Evolutionary Laboratory of Science Cosponsor International Academic Conference, NCRM NICHE 2019, on October 15, 2019 2019-10-21 14:00
Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas 2019-10-18 20:30
China Biologic Special Committee Retains Financial Advisor and Legal Counsel 2019-10-17 20:00
Hepagene Therapeutics, Inc, Announces Dosing of First Healthy Subject in a Phase I Study of HPG1860 for NASH 2019-10-16 18:00
Collaborative Medicinal Development Enrolls First Patient In a Randomized, Placebo-Controlled Clinical Trial of CuATSM For The Treatment of Amyotrophic Lateral Sclerosis 2019-10-15 05:58
STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal 2019-10-14 14:00
Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S. 2019-10-11 13:00
I-Mab Biopharma Receives IND Approval in China for Proprietary CD73 Antibody TJD5 2019-10-04 13:40
Medicago's New Drug Submission accepted for scientific review by Health Canada: An important step for Medicago towards commercialization of its innovative influenza vaccine 2019-10-03 06:30
Mayne Pharma Signs 20-Year Exclusive License and Supply Agreement for Novel Oral Contraceptive in the US 2019-10-02 12:01
1 125 126 127 128 129 165